Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Deiteren A"'
Autor:
Annemie Deiteren, Lieselot Bontinck, Griet Conickx, Marie Vigan, Nele Dervaux, Matthieu Gassiot, Selcuk Bas, Benjamin Suratt, Heribert Staudinger, Emmanuel Krupka
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 6, Pp n/a-n/a (2024)
Abstract Lunsekimig is a novel, bispecific NANOBODY® molecule that inhibits both thymic stromal lymphopoietin (TSLP) and interleukin (IL)‐13, two key mediators of asthma pathophysiology. In this first‐in‐human study, we evaluated the safety, t
Externí odkaz:
https://doaj.org/article/3f3462389a254ce5ae0065a0ea83e68a
Autor:
Deiteren, Annemie1 (AUTHOR) annemie.deiteren@sanofi.com, Bontinck, Lieselot1 (AUTHOR), Conickx, Griet1 (AUTHOR), Vigan, Marie2 (AUTHOR), Dervaux, Nele1 (AUTHOR), Gassiot, Matthieu3 (AUTHOR), Bas, Selcuk4 (AUTHOR), Suratt, Benjamin5 (AUTHOR), Staudinger, Heribert6 (AUTHOR), Krupka, Emmanuel3 (AUTHOR)
Publikováno v:
CTS: Clinical & Translational Science. Jun2024, Vol. 17 Issue 6, p1-14. 14p.
Autor:
Stefan Avey, Meenakshi Chatterjee, Nikolay V. Manyakov, Philip Cooper, Nina Sabins, Kenneth Mosca, Simone Mori, Frédéric Baribaud, Mark Morris, Joseph Lehar, Annemie Deiteren, Marta Cossu, Sophie Smets, Tanja Huizer, Esi Lamousé‐Smith, Kim Campbell, Ioannis Pandis
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 2, Pp n/a-n/a (2024)
Abstract Remote inflammation monitoring with digital health technologies (DHTs) would provide valuable information for both clinical research and care. Controlled perturbations of the immune system may reveal physiological signatures which could be u
Externí odkaz:
https://doaj.org/article/31757f34e81e4febad5645f1db507c31
Autor:
Annemie Deiteren, Erwin Coenen, Sabine Lenders, Peter Verwilst, Erik Mannaert, Freya Rasschaert
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 6, Pp 2450-2460 (2021)
Abstract Protocols for clinical trials describe inclusion and exclusion criteria based on general and compound‐specific considerations to ensure subject safety and data quality. In phase I clinical trials, healthy volunteers (HVs) are screened agai
Externí odkaz:
https://doaj.org/article/4235eb3060a14b7e8e5f2d52ef5832b6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joachim Linssen, Anthony Ermens, Marvin Berrevoets, Michela Seghezzi, Giulia Previtali, Simone van der Sar-van der Brugge, Henk Russcher, Annelies Verbon, Judith Gillis, Jürgen Riedl, Eva de Jongh, Jarob Saker, Marion Münster, Imke CA Munnix, Anthonius Dofferhof, Volkher Scharnhorst, Heidi Ammerlaan, Kathleen Deiteren, Stephan JL Bakker, Lucas Joost Van Pelt, Yvette Kluiters-de Hingh, Mathie PG Leers, Andre J van der Ven
Publikováno v:
eLife, Vol 9 (2020)
COVID-19 induces haemocytometric changes. Complete blood count changes, including new cell activation parameters, from 982 confirmed COVID-19 adult patients from 11 European hospitals were retrospectively analysed for distinctive patterns based on ag
Externí odkaz:
https://doaj.org/article/d0f18f38e8b44385bc7777229cacf794
Autor:
Anguille, Sébastien *, Van de Velde, Ann L. *, Smits, Evelien L. *, Van Tendeloo, Viggo F. *, Juliusson, Gunnar *, Cools, Nathalie, Nijs, Griet, Stein, Barbara, Lion, Eva, Van Driessche, Ann, Vandenbosch, Irma, Verlinden, Anke, Gadisseur, Alain P., Schroyens, Wilfried A., Muylle, Ludo, Vermeulen, Katrien, Maes, Marie-Berthe, Deiteren, Kathleen, Malfait, Ronald, Gostick, Emma, Lammens, Martin, Couttenye, Marie M., Jorens, Philippe, Goossens, Herman, Price, David A., Ladell, Kristin, Oka, Yoshihiro, Fujiki, Fumihiro, Oji, Yusuke, Sugiyama, Haruo, Berneman, Zwi N.
Publikováno v:
In Blood 12 October 2017 130(15):1713-1721
Autor:
Deiteren, Annemie1 (AUTHOR), Coenen, Erwin1 (AUTHOR) Ecoenen1@its.jnj.com, Lenders, Sabine1 (AUTHOR), Verwilst, Peter1 (AUTHOR), Mannaert, Erik1 (AUTHOR), Rasschaert, Freya1 (AUTHOR)
Publikováno v:
CTS: Clinical & Translational Science. Nov2021, Vol. 14 Issue 6, p2450-2460. 11p.
Autor:
Freya Rasschaert, Annemie Deiteren, Sabine Lenders, Erwin Coenen, Peter Verwilst, Erik Mannaert
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 6, Pp 2450-2460 (2021)
Clinical and Translational Science, Vol 14, Iss 6, Pp 2450-2460 (2021)
Protocols for clinical trials describe inclusion and exclusion criteria based on general and compound‐specific considerations to ensure subject safety and data quality. In phase I clinical trials, healthy volunteers (HVs) are screened against these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::857187e003f876bb95115d45e8e74320
https://doi.org/10.1111/cts.13113
https://doi.org/10.1111/cts.13113